Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Bretylium
General information
Bretylium, originally introduced as a hypotensive agent but no longer used as such, has not been extensively used as an antidysrhythmic drug. Its clinical pharmacology, uses, efficacy, and adverse effects have been reviewed [ ]. Adverse reactions have reportedly caused the need for withdrawal in about 7% of patients [ ].
Organs and systems
You're Reading a Preview
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here